![Cariad Chester](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cariad Chester
Direttore/Membro del Consiglio presso
Plexium, Inc.
Profilo
Cariad Chester is currently the Director at Plexium, Inc. since 2022 and a Partner at both The Column Group LLC and TCG Crossover Management LLC since 2021.
Previously, Cariad worked as the Managing Director at Aquilo Capital Management LLC from 2015 to 2021.
Additionally, Cariad held the position of Director at Tourmaline Sub, Inc. in 2023 and was a Director at Tourmaline Bio, Inc. Cariad completed their undergraduate degree at Swarthmore College.
Posizioni attive di Cariad Chester
| Società | Posizione | Inizio |
|---|---|---|
The Column Group LLC
 The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Investitore di Private Equity | 01/01/2021 |
Plexium, Inc.
 Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Direttore/Membro del Consiglio | 23/02/2022 |
TCG Crossover Management LLC
 TCG Crossover Management LLC Investment ManagersFinance TCG Crossover Management invests in both public and private companies located in North America, China and Europe. The firm targets companies operating in the fields of drug discovery and development sectors. It provides financing for later stage capital requirements. | Investitore di Private Equity | 01/01/2021 |
Precedenti posizioni note di Cariad Chester
| Società | Posizione | Fine |
|---|---|---|
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Direttore/Membro del Consiglio | 29/11/2023 |
Aquilo Capital Management LLC
 Aquilo Capital Management LLC Investment ManagersFinance Aquilo manages funds that generally focus on the life sciences industry, with a specific focus on biotechnology and drug discovery and development companies. The firm employs deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies with the potential to alter the practice of medicine in profound ways. Their goal is to provide long- term clients and investors with a high rate of return relative to risk over time. | Analyst-Equity | 31/12/2021 |
Formazione di Cariad Chester
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
62
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Swarthmore College
 Swarthmore College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Column Group LLC
The Column Group LLC Investment ManagersFinance TCG invests in companies located in the United States. The firm focuses on drug discovery, biology, chemistry, and technology sectors. It provides financing for early and later stage capital requirements with an investment size of USD 50 - 60 million. | Finance |
Aquilo Capital Management LLC
Aquilo Capital Management LLC Investment ManagersFinance Aquilo manages funds that generally focus on the life sciences industry, with a specific focus on biotechnology and drug discovery and development companies. The firm employs deep sector expertise and a disciplined, value-oriented process to identify extraordinary biotech companies with the potential to alter the practice of medicine in profound ways. Their goal is to provide long- term clients and investors with a high rate of return relative to risk over time. | Finance |
Plexium, Inc.
Plexium, Inc. BiotechnologyHealth Technology Develops drug discovery and targeted protein degradation therapeutics technology platform | Health Technology |
TCG Crossover Management LLC
TCG Crossover Management LLC Investment ManagersFinance TCG Crossover Management invests in both public and private companies located in North America, China and Europe. The firm targets companies operating in the fields of drug discovery and development sectors. It provides financing for later stage capital requirements. | Finance |
Tourmaline Bio, Inc.
Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical biotechnology company developing transformative medicines | Commercial Services |
